Colin Tasi
Senior Principal
Senior Principal
Colin is a Senior Principal with Cerity Partners Ventures’ team in Boston. He focuses on early- and growth-stage investments in biotechnology, digital health, and pharmaceutical manufacturing.
Prior to joining Cerity Partners, Colin was a Senior Associate at Touchdown Ventures, a pioneer of the “venture capital as a service” model that merged with Cerity Partners in 2024. Colin joined Touchdown after completing his residency in emergency medicine at Harvard (MGH/BWH), during which he worked with the venture investment teams at RA Capital and Valtruis. He has also held positions at multiple hospital systems in operations and growth strategy, and he has a research background in cellular biology.
Learn more about Cerity Partners Corporate Venture Capital.
Senior Associate
Senior Associate
Partner
Associate
Venture Advisor
Partner
Partner
Principal
Principal
Associate
Senior Principal
Senior Principal
Senior Principal
Senior Associate
Senior Associate
Venture Advisor
Partner
Partner
Senior Associate
Senior Associate
Partner
Senior Principal
Partner
Partner
Partner
Principal
Senior Associate
Senior Associate
Senior Principal
Principal
Principal
Partner
Partner
Principal
Senior Principal
Partner
Senior Principal
Senior Principal